Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy
Publication
, Conference
Jarskog, FF; Grove, RA; McEvoy, JP; Keefe, RSE; Lowy, MT; Horrigan, JP; Peykamian, MA
Published in: BIOLOGICAL PSYCHIATRY
April 15, 2012
Duke Scholars
Published In
BIOLOGICAL PSYCHIATRY
ISSN
0006-3223
Publication Date
April 15, 2012
Volume
71
Issue
8
Start / End Page
63S / 64S
Location
Philadelphia, PA
Publisher
ELSEVIER SCIENCE INC
Conference Name
67th Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry
Related Subject Headings
- Psychiatry
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jarskog, F. F., Grove, R. A., McEvoy, J. P., Keefe, R. S. E., Lowy, M. T., Horrigan, J. P., & Peykamian, M. A. (2012). Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy. In BIOLOGICAL PSYCHIATRY (Vol. 71, pp. 63S-64S). Philadelphia, PA: ELSEVIER SCIENCE INC.
Jarskog, F Fredrik, Richard A. Grove, Joseph P. McEvoy, Richard S. E. Keefe, Martin T. Lowy, Joseph P. Horrigan, and Margaret A. Peykamian. “Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy.” In BIOLOGICAL PSYCHIATRY, 71:63S-64S. ELSEVIER SCIENCE INC, 2012.
Jarskog FF, Grove RA, McEvoy JP, Keefe RSE, Lowy MT, Horrigan JP, et al. Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy. In: BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC; 2012. p. 63S-64S.
Jarskog, F. Fredrik, et al. “Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy.” BIOLOGICAL PSYCHIATRY, vol. 71, no. 8, ELSEVIER SCIENCE INC, 2012, pp. 63S-64S.
Jarskog FF, Grove RA, McEvoy JP, Keefe RSE, Lowy MT, Horrigan JP, Peykamian MA. Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy. BIOLOGICAL PSYCHIATRY. ELSEVIER SCIENCE INC; 2012. p. 63S-64S.
Published In
BIOLOGICAL PSYCHIATRY
ISSN
0006-3223
Publication Date
April 15, 2012
Volume
71
Issue
8
Start / End Page
63S / 64S
Location
Philadelphia, PA
Publisher
ELSEVIER SCIENCE INC
Conference Name
67th Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry
Related Subject Headings
- Psychiatry
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences